ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pirfenidone Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-20K9571
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pirfenidone Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pirfenidone Market Research Report 2025

Code: QYRE-Auto-20K9571
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla Ltd
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
WOCKHARDT
Incepta Pharmaceuticals
Unimed Unihealth

Pirfenidone Market

The global market for Pirfenidone was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pirfenidone is a medication used for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and thickening of the lung tissue. Pirfenidone works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II, which are involved in the formation of scar tissue. Pirfenidone is available as a tablet or a capsule, and it is taken orally with food three times a day.
The future market trends of Pirfenidone are expected to be influenced by the following factors:The increasing prevalence of IPF, especially among the elderly population, and the rising awareness and diagnosis of the disease.The growing research and development activities in fibrotic diseases, and the emergence of new drugs and formulations that may offer better efficacy and safety than Pirfenidone.The expansion of the market in emerging regions, such as Asia-Pacific and Latin America, where Pirfenidone has been approved or is under review by regulatory authorities.The impact of the COVID-19 pandemic, which may increase the risk of IPF among patients who have recovered from the infection, and also pose challenges for the supply chain and distribution of Pirfenidone.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pirfenidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pirfenidone.
The Pirfenidone market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pirfenidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pirfenidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pirfenidone Market Report

Report Metric Details
Report Name Pirfenidone Market
Segment by Type
  • Tablet
  • Capsule
  • Others
Segment by Application
  • Mild Idiopathic Pulmonary Fibrosis
  • Moderate Idiopathic Pulmonary Fibrosis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals, Koye Pharmaceuticals, MSN Laboratories, Wockhardt, Incepta Pharmaceuticals, Unimed Unihealth
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pirfenidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pirfenidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pirfenidone Market report?

Ans: The main players in the Pirfenidone Market are Genentech (Roche), Shionogi, GNI Group, Beijing Continent, Cipla, Lupin Ltd, Zydus Cadila, Glenmark Pharmaceuticals, Koye Pharmaceuticals, MSN Laboratories, Wockhardt, Incepta Pharmaceuticals, Unimed Unihealth

What are the Application segmentation covered in the Pirfenidone Market report?

Ans: The Applications covered in the Pirfenidone Market report are Mild Idiopathic Pulmonary Fibrosis, Moderate Idiopathic Pulmonary Fibrosis, Others

What are the Type segmentation covered in the Pirfenidone Market report?

Ans: The Types covered in the Pirfenidone Market report are Tablet, Capsule, Others

1 Pirfenidone Market Overview
1.1 Product Definition
1.2 Pirfenidone by Type
1.2.1 Global Pirfenidone Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Others
1.3 Pirfenidone by Application
1.3.1 Global Pirfenidone Market Value by Application (2024 VS 2031)
1.3.2 Mild Idiopathic Pulmonary Fibrosis
1.3.3 Moderate Idiopathic Pulmonary Fibrosis
1.3.4 Others
1.4 Global Pirfenidone Market Size Estimates and Forecasts
1.4.1 Global Pirfenidone Revenue 2020-2031
1.4.2 Global Pirfenidone Sales 2020-2031
1.4.3 Global Pirfenidone Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pirfenidone Market Competition by Manufacturers
2.1 Global Pirfenidone Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pirfenidone Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pirfenidone Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pirfenidone, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pirfenidone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pirfenidone, Product Type & Application
2.7 Global Key Manufacturers of Pirfenidone, Date of Enter into This Industry
2.8 Global Pirfenidone Market Competitive Situation and Trends
2.8.1 Global Pirfenidone Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pirfenidone Players Market Share by Revenue
2.8.3 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pirfenidone Market Scenario by Region
3.1 Global Pirfenidone Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pirfenidone Sales by Region: 2020-2031
3.2.1 Global Pirfenidone Sales by Region: 2020-2025
3.2.2 Global Pirfenidone Sales by Region: 2026-2031
3.3 Global Pirfenidone Revenue by Region: 2020-2031
3.3.1 Global Pirfenidone Revenue by Region: 2020-2025
3.3.2 Global Pirfenidone Revenue by Region: 2026-2031
3.4 North America Pirfenidone Market Facts & Figures by Country
3.4.1 North America Pirfenidone Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pirfenidone Sales by Country (2020-2031)
3.4.3 North America Pirfenidone Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pirfenidone Market Facts & Figures by Country
3.5.1 Europe Pirfenidone Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pirfenidone Sales by Country (2020-2031)
3.5.3 Europe Pirfenidone Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pirfenidone Market Facts & Figures by Region
3.6.1 Asia Pacific Pirfenidone Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pirfenidone Sales by Region (2020-2031)
3.6.3 Asia Pacific Pirfenidone Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pirfenidone Market Facts & Figures by Country
3.7.1 Latin America Pirfenidone Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pirfenidone Sales by Country (2020-2031)
3.7.3 Latin America Pirfenidone Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pirfenidone Market Facts & Figures by Country
3.8.1 Middle East and Africa Pirfenidone Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pirfenidone Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pirfenidone Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pirfenidone Sales by Type (2020-2031)
4.1.1 Global Pirfenidone Sales by Type (2020-2025)
4.1.2 Global Pirfenidone Sales by Type (2026-2031)
4.1.3 Global Pirfenidone Sales Market Share by Type (2020-2031)
4.2 Global Pirfenidone Revenue by Type (2020-2031)
4.2.1 Global Pirfenidone Revenue by Type (2020-2025)
4.2.2 Global Pirfenidone Revenue by Type (2026-2031)
4.2.3 Global Pirfenidone Revenue Market Share by Type (2020-2031)
4.3 Global Pirfenidone Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pirfenidone Sales by Application (2020-2031)
5.1.1 Global Pirfenidone Sales by Application (2020-2025)
5.1.2 Global Pirfenidone Sales by Application (2026-2031)
5.1.3 Global Pirfenidone Sales Market Share by Application (2020-2031)
5.2 Global Pirfenidone Revenue by Application (2020-2031)
5.2.1 Global Pirfenidone Revenue by Application (2020-2025)
5.2.2 Global Pirfenidone Revenue by Application (2026-2031)
5.2.3 Global Pirfenidone Revenue Market Share by Application (2020-2031)
5.3 Global Pirfenidone Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Genentech (Roche)
6.1.1 Genentech (Roche) Company Information
6.1.2 Genentech (Roche) Description and Business Overview
6.1.3 Genentech (Roche) Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Genentech (Roche) Pirfenidone Product Portfolio
6.1.5 Genentech (Roche) Recent Developments/Updates
6.2 Shionogi
6.2.1 Shionogi Company Information
6.2.2 Shionogi Description and Business Overview
6.2.3 Shionogi Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shionogi Pirfenidone Product Portfolio
6.2.5 Shionogi Recent Developments/Updates
6.3 GNI Group
6.3.1 GNI Group Company Information
6.3.2 GNI Group Description and Business Overview
6.3.3 GNI Group Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GNI Group Pirfenidone Product Portfolio
6.3.5 GNI Group Recent Developments/Updates
6.4 Beijing Continent
6.4.1 Beijing Continent Company Information
6.4.2 Beijing Continent Description and Business Overview
6.4.3 Beijing Continent Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Beijing Continent Pirfenidone Product Portfolio
6.4.5 Beijing Continent Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cipla Pirfenidone Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Lupin Ltd
6.6.1 Lupin Ltd Company Information
6.6.2 Lupin Ltd Description and Business Overview
6.6.3 Lupin Ltd Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lupin Ltd Pirfenidone Product Portfolio
6.6.5 Lupin Ltd Recent Developments/Updates
6.7 Zydus Cadila
6.7.1 Zydus Cadila Company Information
6.7.2 Zydus Cadila Description and Business Overview
6.7.3 Zydus Cadila Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zydus Cadila Pirfenidone Product Portfolio
6.7.5 Zydus Cadila Recent Developments/Updates
6.8 Glenmark Pharmaceuticals
6.8.1 Glenmark Pharmaceuticals Company Information
6.8.2 Glenmark Pharmaceuticals Description and Business Overview
6.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Glenmark Pharmaceuticals Pirfenidone Product Portfolio
6.8.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.9 Koye Pharmaceuticals
6.9.1 Koye Pharmaceuticals Company Information
6.9.2 Koye Pharmaceuticals Description and Business Overview
6.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Koye Pharmaceuticals Pirfenidone Product Portfolio
6.9.5 Koye Pharmaceuticals Recent Developments/Updates
6.10 MSN Laboratories
6.10.1 MSN Laboratories Company Information
6.10.2 MSN Laboratories Description and Business Overview
6.10.3 MSN Laboratories Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MSN Laboratories Pirfenidone Product Portfolio
6.10.5 MSN Laboratories Recent Developments/Updates
6.11 Wockhardt
6.11.1 Wockhardt Company Information
6.11.2 Wockhardt Description and Business Overview
6.11.3 Wockhardt Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Wockhardt Pirfenidone Product Portfolio
6.11.5 Wockhardt Recent Developments/Updates
6.12 Incepta Pharmaceuticals
6.12.1 Incepta Pharmaceuticals Company Information
6.12.2 Incepta Pharmaceuticals Description and Business Overview
6.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Incepta Pharmaceuticals Pirfenidone Product Portfolio
6.12.5 Incepta Pharmaceuticals Recent Developments/Updates
6.13 Unimed Unihealth
6.13.1 Unimed Unihealth Company Information
6.13.2 Unimed Unihealth Description and Business Overview
6.13.3 Unimed Unihealth Pirfenidone Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Unimed Unihealth Pirfenidone Product Portfolio
6.13.5 Unimed Unihealth Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pirfenidone Industry Chain Analysis
7.2 Pirfenidone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pirfenidone Production Mode & Process Analysis
7.4 Pirfenidone Sales and Marketing
7.4.1 Pirfenidone Sales Channels
7.4.2 Pirfenidone Distributors
7.5 Pirfenidone Customer Analysis
8 Pirfenidone Market Dynamics
8.1 Pirfenidone Industry Trends
8.2 Pirfenidone Market Drivers
8.3 Pirfenidone Market Challenges
8.4 Pirfenidone Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla Ltd
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
WOCKHARDT
Incepta Pharmaceuticals
Unimed Unihealth
List of Tables
 Table 1. Global Pirfenidone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pirfenidone Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pirfenidone Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pirfenidone Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Pirfenidone Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pirfenidone Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pirfenidone Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pirfenidone Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pirfenidone, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pirfenidone, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pirfenidone, Product Type & Application
 Table 12. Global Key Manufacturers of Pirfenidone, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pirfenidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pirfenidone as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pirfenidone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pirfenidone Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Pirfenidone Sales Market Share by Region (2020-2025)
 Table 19. Global Pirfenidone Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Pirfenidone Sales Market Share by Region (2026-2031)
 Table 21. Global Pirfenidone Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pirfenidone Revenue Market Share by Region (2020-2025)
 Table 23. Global Pirfenidone Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pirfenidone Revenue Market Share by Region (2026-2031)
 Table 25. North America Pirfenidone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pirfenidone Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Pirfenidone Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Pirfenidone Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pirfenidone Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pirfenidone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pirfenidone Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Pirfenidone Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Pirfenidone Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pirfenidone Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pirfenidone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pirfenidone Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Pirfenidone Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Pirfenidone Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pirfenidone Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pirfenidone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pirfenidone Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Pirfenidone Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Pirfenidone Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pirfenidone Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pirfenidone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pirfenidone Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Pirfenidone Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Pirfenidone Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pirfenidone Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pirfenidone Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Pirfenidone Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Pirfenidone Sales Market Share by Type (2020-2025)
 Table 53. Global Pirfenidone Sales Market Share by Type (2026-2031)
 Table 54. Global Pirfenidone Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pirfenidone Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pirfenidone Revenue Market Share by Type (2020-2025)
 Table 57. Global Pirfenidone Revenue Market Share by Type (2026-2031)
 Table 58. Global Pirfenidone Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Pirfenidone Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Pirfenidone Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Pirfenidone Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Pirfenidone Sales Market Share by Application (2020-2025)
 Table 63. Global Pirfenidone Sales Market Share by Application (2026-2031)
 Table 64. Global Pirfenidone Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pirfenidone Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pirfenidone Revenue Market Share by Application (2020-2025)
 Table 67. Global Pirfenidone Revenue Market Share by Application (2026-2031)
 Table 68. Global Pirfenidone Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Pirfenidone Price (USD/Pcs) by Application (2026-2031)
 Table 70. Genentech (Roche) Company Information
 Table 71. Genentech (Roche) Description and Business Overview
 Table 72. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Genentech (Roche) Pirfenidone Product
 Table 74. Genentech (Roche) Recent Developments/Updates
 Table 75. Shionogi Company Information
 Table 76. Shionogi Description and Business Overview
 Table 77. Shionogi Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Shionogi Pirfenidone Product
 Table 79. Shionogi Recent Developments/Updates
 Table 80. GNI Group Company Information
 Table 81. GNI Group Description and Business Overview
 Table 82. GNI Group Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. GNI Group Pirfenidone Product
 Table 84. GNI Group Recent Developments/Updates
 Table 85. Beijing Continent Company Information
 Table 86. Beijing Continent Description and Business Overview
 Table 87. Beijing Continent Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Beijing Continent Pirfenidone Product
 Table 89. Beijing Continent Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Cipla Pirfenidone Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Lupin Ltd Company Information
 Table 96. Lupin Ltd Description and Business Overview
 Table 97. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Lupin Ltd Pirfenidone Product
 Table 99. Lupin Ltd Recent Developments/Updates
 Table 100. Zydus Cadila Company Information
 Table 101. Zydus Cadila Description and Business Overview
 Table 102. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Zydus Cadila Pirfenidone Product
 Table 104. Zydus Cadila Recent Developments/Updates
 Table 105. Glenmark Pharmaceuticals Company Information
 Table 106. Glenmark Pharmaceuticals Description and Business Overview
 Table 107. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Glenmark Pharmaceuticals Pirfenidone Product
 Table 109. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 110. Koye Pharmaceuticals Company Information
 Table 111. Koye Pharmaceuticals Description and Business Overview
 Table 112. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Koye Pharmaceuticals Pirfenidone Product
 Table 114. Koye Pharmaceuticals Recent Developments/Updates
 Table 115. MSN Laboratories Company Information
 Table 116. MSN Laboratories Description and Business Overview
 Table 117. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. MSN Laboratories Pirfenidone Product
 Table 119. MSN Laboratories Recent Developments/Updates
 Table 120. Wockhardt Company Information
 Table 121. Wockhardt Description and Business Overview
 Table 122. Wockhardt Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Wockhardt Pirfenidone Product
 Table 124. Wockhardt Recent Developments/Updates
 Table 125. Incepta Pharmaceuticals Company Information
 Table 126. Incepta Pharmaceuticals Description and Business Overview
 Table 127. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Incepta Pharmaceuticals Pirfenidone Product
 Table 129. Incepta Pharmaceuticals Recent Developments/Updates
 Table 130. Unimed Unihealth Company Information
 Table 131. Unimed Unihealth Description and Business Overview
 Table 132. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Unimed Unihealth Pirfenidone Product
 Table 134. Unimed Unihealth Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Pirfenidone Distributors List
 Table 138. Pirfenidone Customers List
 Table 139. Pirfenidone Market Trends
 Table 140. Pirfenidone Market Drivers
 Table 141. Pirfenidone Market Challenges
 Table 142. Pirfenidone Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pirfenidone
 Figure 2. Global Pirfenidone Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pirfenidone Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Pirfenidone Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pirfenidone Market Share by Application: 2024 & 2031
 Figure 9. Mild Idiopathic Pulmonary Fibrosis
 Figure 10. Moderate Idiopathic Pulmonary Fibrosis
 Figure 11. Others
 Figure 12. Global Pirfenidone Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pirfenidone Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Pirfenidone Sales (2020-2031) & (K Pcs)
 Figure 15. Global Pirfenidone Average Price (USD/Pcs) & (2020-2031)
 Figure 16. Pirfenidone Report Years Considered
 Figure 17. Pirfenidone Sales Share by Manufacturers in 2024
 Figure 18. Global Pirfenidone Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Pirfenidone Players: Market Share by Revenue in Pirfenidone in 2024
 Figure 20. Pirfenidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Pirfenidone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Pirfenidone Sales Market Share by Country (2020-2031)
 Figure 23. North America Pirfenidone Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Pirfenidone Sales Market Share by Country (2020-2031)
 Figure 27. Europe Pirfenidone Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Pirfenidone Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Pirfenidone Revenue Market Share by Region (2020-2031)
 Figure 35. China Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Pirfenidone Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Pirfenidone Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Pirfenidone Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Pirfenidone Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Pirfenidone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Pirfenidone by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Pirfenidone by Type (2020-2031)
 Figure 57. Global Pirfenidone Price (USD/Pcs) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Pirfenidone by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Pirfenidone by Application (2020-2031)
 Figure 60. Global Pirfenidone Price (USD/Pcs) by Application (2020-2031)
 Figure 61. Pirfenidone Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Pirfenidone Drugs Market Research Report 2024
Global Afidopyropen Market Research Report 2024
Global Nitrendipine Market Research Report 2025
Global Flurbiprofen Market Research Report 2024
Global Flutriafol Market Research Report 2025
Global Sparfloxacin Market Research Report 2024
Global Nitisinone Drug Market Research Report 2024
Global Fluticasone Market Research Report 2024
Global Prometryn Market Research Report 2025
Global Rilpivirine Market Research Report 2024
Global Urapidil Market Research Report 2024
Global Prednisone Market Research Report 2025
Global Dabrafenib Market Research Report 2025
Global Difenuron Market Research Report 2025
Global Pirfenidone Tablets Market Research Report 2024
Global Cyflufenamid Market Research Report 2024
Global Revefenacin Market Research Report 2024
Global Zofenopril Market Research Report 2025
Global Perflubron Market Research Report 2025
Global 4 Bromopyridazine Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions